deltatrials
Completed OBSERVATIONAL NCT02454803

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice (ULIS III)

An International, Multicentre, Observational, Prospective, Longitudinal Cohort Study to Assess the Impact of Integrated Upper Limb Spasticity Management Including the Use of BoNT-A- Injections on Patient-centred Goal Attainment in Real Life Practice - ULIS III

Sponsor: Ipsen

Conditions Upper Limb Spasticity
Updated 15 times since 2017 Last updated: Aug 1, 2019 Started: Jan 31, 2015 Primary completion: Jun 3, 2019 Completion: Jun 3, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02454803, this observational or N/A phase trial focuses on Upper Limb Spasticity and remains completed. Sponsored by Ipsen, it has been updated 15 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Mar 2018 · 9 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Jul 2019 · 5 months · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 9 months · monthly snapshot

Change History

15 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed

  2. Sep 2025 — Oct 2025 [monthly]

    Completed

  3. Sep 2024 — Sep 2025 [monthly]

    Completed

  4. Jul 2024 — Sep 2024 [monthly]

    Completed

  5. Jan 2021 — Jul 2024 [monthly]

    Completed

▶ Show 10 earlier versions

  1. Sep 2019 — Jan 2021 [monthly]

    Completed

  2. Jul 2019 — Sep 2019 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  3. Feb 2019 — Jul 2019 [monthly]

    Active Not Recruiting

  4. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting

  5. Aug 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  6. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  7. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  8. Mar 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

  9. Jun 2017 — Mar 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  10. Jan 2017 — Jun 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ipsen
Data source: Ipsen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alcoitão, Portugal , Ancona, Italy , Angers, France , Bari, Italy , Barnaul, Russia , Bordeaux, France , Camberwell, Australia , Cebu City, Philippines , Chicago, United States , Costa Masnaga, Italy and 43 more locations